Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by St. John Providence Health System.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Genentech, Inc.
Eli Lilly and Company
Information provided by:
St. John Providence Health System
ClinicalTrials.gov Identifier:
NCT00150657
First received: September 6, 2005
Last updated: November 28, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given